Skip to main content
. 2018 Sep 1;11(9):4363–4373.

Table 3.

Patient response to second-line chemotherapy (n = 54)

Variable CR+PR SD+PD P-value CR+PR+SD PD P-value
CC3 expression
    Negative 5 23 0.218 11 17 0.033
    Positive 9 17 18 8
Ki-67 risk
    ≤ 30% 3 9 1.000 10 2 0.024
    > 30% 11 31 19 23
E-cad
    Negative 4 13 1.000 5 12 0.020
    Positive 10 27 24 13

CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease.